VEGF-A and PAIP2 in Head and Neck Cancer
Author Information
Author(s): Onesto C, Hannoun-Lévi J-M, Chamorey E, Formento J-L, Ramaioli A, Pagès G
Primary Institution: Institute of Signalling, Developmental Biology and Cancer Research, CNRS – UMR 6543, University of Nice Sophia-Antipolis
Hypothesis
Is there a correlation between VEGF-A and PAIP2 expression in head and neck squamous cell carcinomas (HNSCC)?
Conclusion
VEGF-A expression is a significant prognostic marker in head and neck cancer, while PAIP2 does not correlate with patient outcomes.
Supporting Evidence
- VEGF-A expression is correlated with the stage of tumor differentiation.
- High VEGF-A levels predict a higher rate of disease recurrence and shorter progression-free survival.
- PAIP2 expression does not correlate with clinicopathological factors or patient survival.
Takeaway
This study found that higher levels of a protein called VEGF-A in head and neck cancer can mean a worse outcome for patients, while another protein, PAIP2, doesn't seem to affect survival.
Methodology
The study quantitatively evaluated VEGF-A and PAIP2 protein levels in tumor tissue homogenates from 54 patients and analyzed their correlation with clinicopathological parameters.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the reliance on previously collected clinical data.
Limitations
The study is retrospective and may be affected by biases in patient selection and the methods used for protein detection.
Participant Demographics
Median age at diagnosis was 57 years, with a male to female ratio of 2.4:1.
Statistical Information
P-Value
p=0.001
Confidence Interval
(1.54–6.48)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website